Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Oftyll is a brand of over-the-counter (OTC) ocular care medical devices developed by Omisan Farmaceutici. The product line encompasses a variety of contact lens maintenance solutions and lubricating eye drops designed to address ocular irritation, dryness, and lens hygiene. Key products include multipurpose solutions like Oftyll Monogreen, which are formulated for cleaning, disinfecting, and hydrating contact lenses. Common ingredients across the Oftyll range include sodium hyaluronate, which serves as a mucomimetic lubricant to stabilize the tear film, and antimicrobial agents such as polyhexamethylene biguanide (PHMB) for lens disinfection. These products are primarily indicated for individuals experiencing symptoms of dry eye syndrome or those requiring specialized care for contact lens wear.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Oftyll.